77 related articles for article (PubMed ID: 10869889)
1. Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.
Kubera M; Kenis G; Bosmans E; Scharpé S; Maes M
Neuropsychopharmacology; 2000 Jul; 23(1):89-98. PubMed ID: 10869889
[TBL] [Abstract][Full Text] [Related]
2. Effects of serotonin and serotonergic agonists and antagonists on the production of tumor necrosis factor alpha and interleukin-6.
Kubera M; Maes M; Kenis G; Kim YK; Lasoń W
Psychiatry Res; 2005 Apr; 134(3):251-8. PubMed ID: 15892984
[TBL] [Abstract][Full Text] [Related]
3. In humans, corticotropin releasing hormone antagonizes some of the negative immunoregulatory effects of serotonin.
Maes M; Kenis G; Kubera M
Neuro Endocrinol Lett; 2003 Dec; 24(6):420-4. PubMed ID: 15073568
[TBL] [Abstract][Full Text] [Related]
4. Negative immunoregulatory effects of noradrenaline through alpha2-adrenoceptor activation.
Maes M; Lin A; Kenis G; Egyed B; Bosmans E
Neuro Endocrinol Lett; 2000; 21(5):375-382. PubMed ID: 11452226
[TBL] [Abstract][Full Text] [Related]
5. Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.
Kubera M; Lin AH; Kenis G; Bosmans E; van Bockstaele D; Maes M
J Clin Psychopharmacol; 2001 Apr; 21(2):199-206. PubMed ID: 11270917
[TBL] [Abstract][Full Text] [Related]
6. The negative immunoregulatory effects of serotonin (5-HT) moduline, an endogenous 5-HT1B receptor antagonist with anti-anxiety properties.
Maes M; Kenis G; Bosmans E
Cytokine; 2002 Sep; 19(6):308-11. PubMed ID: 12421573
[TBL] [Abstract][Full Text] [Related]
7. Why fish oils may not always be adequate treatments for depression or other inflammatory illnesses: docosahexaenoic acid, an omega-3 polyunsaturated fatty acid, induces a Th-1-like immune response.
Maes M; Mihaylova I; Kubera M; Bosmans E
Neuro Endocrinol Lett; 2007 Dec; 28(6):875-80. PubMed ID: 18063921
[TBL] [Abstract][Full Text] [Related]
8. Evidence for 5-HT(1B/1D) and 5-HT(2A) receptors mediating constriction of the canine internal carotid circulation.
Centurión D; Ortiz MI; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):983-90. PubMed ID: 11226128
[TBL] [Abstract][Full Text] [Related]
9. Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms.
Abi-Saab W; Seibyl JP; D'Souza DC; Karper LP; Gueorgueva R; Abi-Dargham A; Wong ML; Rajhans S; Erdos JP; Heninger GR; Charney DS; Krystal JH
Psychopharmacology (Berl); 2002 Jun; 162(1):55-62. PubMed ID: 12107618
[TBL] [Abstract][Full Text] [Related]
10. S32212, a novel serotonin type 2C receptor inverse agonist/α2-adrenoceptor antagonist and potential antidepressant: I. A mechanistic characterization.
Millan MJ; Mannoury la Cour C; Chanrion B; Dupuis DS; Di Cara B; Audinot V; Cussac D; Newman-Tancredi A; Kamal M; Boutin JA; Jockers R; Marin P; Bockaert J; Muller O; Dekeyne A; Lavielle G
J Pharmacol Exp Ther; 2012 Mar; 340(3):750-64. PubMed ID: 22178752
[TBL] [Abstract][Full Text] [Related]
11. The immunoregulatory effects of antidepressants.
Maes M
Hum Psychopharmacol; 2001 Jan; 16(1):95-103. PubMed ID: 12404604
[TBL] [Abstract][Full Text] [Related]
12. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
Misane I; Ogren SO
Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
[TBL] [Abstract][Full Text] [Related]
13. Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study.
Di Giovanni G; Di Matteo V; Di Mascio M; Esposito E
Synapse; 2000 Jan; 35(1):53-61. PubMed ID: 10579808
[TBL] [Abstract][Full Text] [Related]
14. 5-HT1A and beta-adrenergic receptors regulate proliferation of rat blood lymphocytes.
Sempere T; Urbina M; Lima L
Neuroimmunomodulation; 2004; 11(5):307-15. PubMed ID: 15316241
[TBL] [Abstract][Full Text] [Related]
15. The involvement of the serotonergic transmission system in neonatal and adult rat ileum contractility varies with age.
Lobo SB; Denyer M; Britland S; Javid FA
Pharmacology; 2011; 88(3-4):225-32. PubMed ID: 21997518
[TBL] [Abstract][Full Text] [Related]
16. Diltiazem potentiates pentobarbital-induced hypnosis via 5-HT1A and 5-HT2A/2C receptors: role for dorsal raphe nucleus.
Cui SY; Cui XY; Zhang J; Wang ZJ; Yu B; Sheng ZF; Zhang XQ; Shi XL; Zhang YH
Pharmacol Biochem Behav; 2011 Oct; 99(4):566-72. PubMed ID: 21689675
[TBL] [Abstract][Full Text] [Related]
17. Induction of burst firing in ventral tegmental area dopaminergic neurons by activation of serotonin (5-HT)1A receptors: WAY 100,635-reversible actions of the highly selective ligands, flesinoxan and S 15535.
Lejeune F; Millan MJ
Synapse; 1998 Oct; 30(2):172-80. PubMed ID: 9723787
[TBL] [Abstract][Full Text] [Related]
18. Different receptor subtypes are involved in the serotonin-induced modulation of epileptiform activity in rat frontal cortex in vitro.
Bobula B; Zahorodna A; Bijak M
J Physiol Pharmacol; 2001 Jun; 52(2):265-74. PubMed ID: 11453105
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
20. The GR127935-sensitive 5-HT(1) receptors mediating canine internal carotid vasoconstriction: resemblance to the 5-HT(1B), but not to the 5-HT(1D) or 5-ht(1F), receptor subtype.
Centurión D; Sánchez-López A; De Vries P; Saxena PR; Villalón CM
Br J Pharmacol; 2001 Mar; 132(5):991-8. PubMed ID: 11226129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
